These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7963651)
1. Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera. Haftek M; Zone JJ; Taylor TB; Kowalewski C; Chorzelski TP; Schmitt D J Invest Dermatol; 1994 Nov; 103(5):656-9. PubMed ID: 7963651 [TBL] [Abstract][Full Text] [Related]
2. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810 [TBL] [Abstract][Full Text] [Related]
3. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein. Zone JJ; Taylor TB; Kadunce DP; Chorzelski TP; Schachner LA; Huff JC; Meyer LJ; Petersen MJ J Invest Dermatol; 1996 Jun; 106(6):1277-80. PubMed ID: 8752670 [TBL] [Abstract][Full Text] [Related]
4. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134 [TBL] [Abstract][Full Text] [Related]
5. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. Zone JJ; Taylor TB; Kadunce DP; Meyer LJ J Clin Invest; 1990 Mar; 85(3):812-20. PubMed ID: 2107211 [TBL] [Abstract][Full Text] [Related]
6. Linear IgA bullous dermatosis with circulating IgG autoantibodies to the 230 kD epidermal antigen. Honoki K; Muramatsu T; Tsubakimoto A; Shirai T J Dermatol; 1998 Aug; 25(8):503-9. PubMed ID: 9769594 [TBL] [Abstract][Full Text] [Related]
7. 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. Ishiko A; Shimizu H; Masunaga T; Hashimoto T; Dmochowski M; Wojnarowska F; Bhogal BS; Black MM; Nishikawa T J Invest Dermatol; 1996 Apr; 106(4):739-43. PubMed ID: 8618014 [TBL] [Abstract][Full Text] [Related]
8. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens. Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135 [TBL] [Abstract][Full Text] [Related]
10. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. Kanitakis J; Mauduit G; Cozzani E; Badinand P; Faure M; Claudy A Pediatr Dermatol; 1994 Jun; 11(2):139-44. PubMed ID: 8041654 [TBL] [Abstract][Full Text] [Related]
11. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. Lazarova Z; Yancey KB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276 [TBL] [Abstract][Full Text] [Related]
12. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen. Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393 [TBL] [Abstract][Full Text] [Related]
13. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting. Zhou S; Ferguson DJ; Allen J; Wojnarowska F Br J Dermatol; 1998 Oct; 139(4):591-7. PubMed ID: 9892901 [TBL] [Abstract][Full Text] [Related]
14. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Collier P; Wojnarowska F; Allen J; Kirtschig G Dermatology; 1994; 189 Suppl 1():105-7. PubMed ID: 8049544 [TBL] [Abstract][Full Text] [Related]
15. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718 [TBL] [Abstract][Full Text] [Related]
17. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin. Gao SQ; Bystryn JC J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753 [TBL] [Abstract][Full Text] [Related]
19. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. Smith EP; Taylor TB; Meyer LJ; Zone JJ J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534 [TBL] [Abstract][Full Text] [Related]
20. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. Zone JJ; Taylor TB; Meyer LJ; Petersen MJ J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]